Ying-Fang Fan

Ying-Fang Fan


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Drug Discovery Today
Verified
Journal Article
Closed access
XLXin-Yu Liu
Xin-Yu Liu
JWJing-Quan Wang
Jing-Quan Wang
CACharles R. Ashby
Charles R. Ashby
LZLeli Zeng
Leli Zeng
YFYing-Fang Fan
Ying-Fang Fan
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen

1 March 2019 in Biomaterials
Verified
Journal Article
Closed access
GLGuan-Hua Lu
Guan-Hua Lu
WSWen-Ting Shang
Wen-Ting Shang
HDHan Deng
Han Deng
ZHZi-Yu Han
Zi-Yu Han
MHMin Hu
Min Hu
JTJie Tian
Jie Tian

1 December 2016 in Cancer Letters
Verified
Journal Article
Closed access
XLXiaoyuan Liang
Xiaoyuan Liang
WSWenting Shang
Wenting Shang
CCChongwei Chi
Chongwei Chi
CZChaoting Zeng
Chaoting Zeng
KWKun Wang
Kun Wang
JTJie Tian
Jie Tian

1 March 2020 in Experimental Cell Research
Verified
Journal Article
Closed access
LWLiu-Ya Wei
Liu-Ya Wei
ZWZhuo-Xun Wu
Zhuo-Xun Wu
YYYang Yang
Yang Yang
MZMin Zhao
Min Zhao
XMXiang-Yu Ma
Xiang-Yu Ma
YFYing-Fang Fan
Ying-Fang Fan

8 November 2016 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
PDF file
WCWei Cai
Wei Cai
BHBaochun He
Baochun He
YFYing-Fang Fan
Ying-Fang Fan
CFChihua Fang
Chihua Fang
FJFucang Jia
Fucang Jia
This study was to evaluate the accuracy, consistency, and efficiency of three liver volumetry methods— one interactive method, an in-house-developed 3D medical Image Analysis (3DMIA) system, one automatic active shape model (ASM)-based segmentation, and one automatic probabilistic atlas (PA)-guided segmentation method on clinical contrast-enhanced CT images. Forty-two datasets, including 27 normal liver and 15 space-occupying liver lesion patients, were retrospectively included in this study. The three methods — one semiautomatic 3DMIA, one automatic ASM-based, and one automatic PA-based liver volumetry — achieved an accuracy with VD (volume difference) of ?1.69%,?2.75% , and 3.06% in the normal group, respectively, and with VD of ?3.20%,?3.35% , and 4.14% in the space-occupying lesion group, respectively. However, the three methods achieved an efficiency of 27.63 mins, 1.26 mins, 1.18 mins on average, respectively, compared with the manual volumetry, which took 43.98 mins. The high intraclass correlation coefficient between the three methods and the manual method indicated an excellent agreement on liver volumetry. Significant differences in segmentation time were observed between the three methods (3DMIA, ASM, and PA) and the manual volumetry ( p<0.001 ), as well as between the automatic volumetries (ASM and PA) and the semiautomatic volumetry (3DMIA) ( p<0.001 ). The semiautomatic interactive 3DMIA, automatic ASM-based, and automatic PA-based liver volumetry agreed well with manual gold standard in both the normal liver group and the space-occupying lesion group. The ASM- and PA-based automatic segmentation have better efficiency in clinical use. PACS number(s): 87.55.-x

21 February 2020 in Cancers
Verified
Journal Article
Open access
PDF file
GZGuan-Nan Zhang
Guan-Nan Zhang
PGPranav Gupta
Pranav Gupta
MWMing Wang
Ming Wang
ABAnna Maria Barbuti
Anna Maria Barbuti
CACharles R. Ashby
Charles R. Ashby
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen
Although the judicious use of anticancer drugs that target one or more receptor tyrosine kinases constitutes an effective strategy to attenuate tumor growth, drug resistance is commonly encountered in cancer patients. The ATP-binding cassette transporters are one of the major contributors to the development of multidrug resistance as their overexpression significantly decreases the intracellular concentration and thus, the efficacy of certain anticancer drugs. Therefore, the development of treatment strategies that would not be susceptible to efflux or excretion by specific ABC transporters could overcome resistance to treatment. Here, we investigated the anticancer efficacy of saporin, a ribosome-inactivating protein. Since saporin has poor permeability across the cell membrane, it was encapsulated in a lipid-based nanoparticle system (EC16-1) that effectively delivered the formulation (EC16-1/saporin) intracellularly and produced anti-cancer efficacy. EC16-1/saporin, at nanomolar concentrations, significantly inhibited the cellular proliferation of parental and ABCB1- and ABCG2-overexpressing cancer cells. EC16-1/saporin did not significantly alter the subcellular localization of ABCB1 and ABCG2. In addition, EC16-1/saporin induced apoptosis in parental and ABCB1- and ABCG2-overexpressing cancer cells. In a murine model system, EC16-1/saporin significantly inhibited the tumor growth in mice xenografted with parental and ABCB1- and ABCG2-overexpressing cancer cells. Our findings suggest that the EC16-1/saporin combination could potentially be a novel therapeutic treatment in patients with parental or ABCB1- and ABCG2-positive drug-resistant cancers.